Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

VICTOR-E1 data show sustained viral suppression with vicriviroc in HIV patients

Feb. 19, 2008

GeoVax Clade B DNA/MVA HIV/AIDS vaccine to proceed to phase II

Feb. 19, 2008

Improved body composition seen with tesamorelin in HIV-associated lipohypertrophy

Feb. 18, 2008

Activity of RDEA-806 less affected by human serum proteins than other NNRTIs

Feb. 18, 2008

VRX-496 affects HIV replication in phase II trial

Feb. 18, 2008

Novel anti-HIV agents described in recent Merck patent

Feb. 15, 2008

Robust immune responses with multiclade HIV-1 DNA plasmid vaccine in phase I/II studies

Feb. 15, 2008

Results from Merck & Co. HIV vaccine reported at the CROI meeting

Feb. 15, 2008

PF-232798 profiled at the CROI meeting

Feb. 14, 2008

Promising anti-HIV profile for novel NNRTIs developed at Ardea

Feb. 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...